Every open market buy and sale of Opus Genetics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $324K bought and $19.7M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when IRD insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an IRD officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every IRD insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | George MagrathCEO | Sale | 28,258 | $3.90 | $110K | 2,010,636 | Nov 5Form 4 |
| Oct 23, 2026 | George MagrathCEO | Sale | 9,591 | $3.58 | $34K | 2,038,894 | Oct 27Form 4 |
| Oct 23, 2026 | Robert E. GagnonCFO | Sale plan | 14,000 | $3.55 | $50K | 542,375 | Oct 27Form 4 |
| Oct 23, 2026 | Benjamin R YerxaPresident | Sale | 33,189 | $3.54 | $117K | 670,917 | Oct 27Form 4 |
| Oct 23, 2026 | Joseph K SchachleCOO | Sale | 4,767 | $3.56 | $17K | 286,673 | Oct 27Form 4 |
| Sep 30, 2026 | Foundation Fighting Blindness Retinal Degeneration FundDirector | Sale | 556,000 | $4.96 | $2.8M | 3,236,171 | Oct 2Form 4 |
| Sep 3, 2026 | Robert E. GagnonCFO | Sale | 28,000 | $4.54 | $127K | 556,375 | Sep 8Form 4 |
| Jul 23, 2026 | Robert E. GagnonCFO | Sale | 7,783 | $2.95 | $23K | 584,375 | Jul 27Form 4 |
| Jul 23, 2026 | George MagrathCEO | Sale | 9,475 | $2.95 | $28K | 1,731,869 | Jul 27Form 4 |
| Jul 23, 2026 | Joseph K SchachleCOO | Sale | 4,644 | $2.94 | $14K | 291,440 | Jul 27Form 4 |
| Jul 23, 2026 | Benjamin R YerxaPresident | Sale | 7,429 | $2.97 | $22K | 704,106 | Jul 27Form 4 |
| May 18, 2026 | Foundation Fighting Blindness Retinal Degeneration FundDirector | Sale | 1,700,000 | $4.35 | $7.4M | 3,792,171 | May 20Form 4 |
| Apr 23, 2026 | Robert E. GagnonCFO | Sale | 7,842 | $5.18 | $41K | 592,158 | Apr 27Form 4 |
| Apr 23, 2026 | Ashwath JayagopalChief Scientific & Dev. Ofc. | Sale | 7,542 | $5.19 | $39K | 509,233 | Apr 27Form 4 |
| Apr 23, 2026 | George MagrathCEO | Sale | 9,511 | $5.22 | $50K | 1,741,344 | Apr 27Form 4 |
IRD insider trading FAQ
Are IRD insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $324K of IRD on the open market in 1 trades, and 7 sold $19.7M in 23 trades.
When did an IRD insider last buy shares?
Cam Gallagher (Director) bought 164,000 shares for $324K on Dec 29, 2025, reported on Dec 31, 2025.
When did an IRD insider last sell shares?
George Magrath (CEO) sold 28,258 shares for $110K on Nov 3, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
